Effect of External Magnetic Field on IV 99mTc-Labeled Aminosilane-Coated Iron Oxide Nanoparticles: Demonstration in a Rat Model: Special Report

ABSTRACTAmong the most interesting applications of ferromagnetic nanoparticles (NPs) in medicine is the potential for localizing pharmacologically or radioactively tagged agents directly to selected tissues selected by an adjustable external magnetic field. This concept is demonstrated by the applic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nuclear medicine 2015-02, Vol.40 (2), p.e104-e110
Hauptverfasser: Liberatore, Mauro, Barteri, Mario, Megna, Valentina, D’Elia, Piera, Rebonato, Stefania, Latini, Augusto, De Angelis, Francesca, Scaramuzzo, Francesca Anna, De Stefano, Maria Egle, Guadagno, Noemi Antonella, Chondrogiannis, Sotirios, Maffione, Anna Margherita, Rubello, Domenico, Pala, Alessandro, Colletti, Patrick M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACTAmong the most interesting applications of ferromagnetic nanoparticles (NPs) in medicine is the potential for localizing pharmacologically or radioactively tagged agents directly to selected tissues selected by an adjustable external magnetic field. This concept is demonstrated by the application external magnetic field on IV Tc-labeled aminosilane-coated iron oxide NPs in a rat model. In a model comparing a rat with a 0.3-T magnet over a hind paw versus a rat without a magnet, a static acquisition at 45 minutes showed that 27% of the administered radioactivity was in the area subtended by the magnet, whereas the liver displays a percentage of binding of 14% in the presence of the magnet and of 16% in the absence of an external magnetic field. These preliminary results suggest that the application of an external magnetic field may be a viable route for the development of methods for the confinement of magnetic NPs labeled with radioactive isotopes targeted for predetermined sites of the body.
ISSN:0363-9762
1536-0229
DOI:10.1097/RLU.0000000000000672